Company Filing History:
Years Active: 1987-1992
Title: **Algis Anilionis: A Pioneer in Recombinant Protein Research**
Introduction
Algis Anilionis is a prominent inventor based in Arlington, MA, known for his significant contributions to the field of biotechnology. With a total of six patents to his name, he has made impactful advancements in recombinant protein technologies, particularly in the cloning and expression of protein A-like materials.
Latest Patents
Among Algis Anilionis's latest patents are two groundbreaking inventions. The first patent involves the cloning of genes encoding recombinant protein A. This innovation describes the successful cloning and characterization of a gene that codes for a protein A-like material. The disclosed nucleotide sequence allows for the production of this material in various host-vector systems, benefiting numerous diagnostic test systems by providing alternatives to traditional protein A. This material exhibits the properties of binding to IgG at the Fc region and activating polyclonal antibody synthesis, making it useful in similar applications.
The second patent is directed toward a novel Bacillus thuringiensis kurstaki delta-endotoxin produced using a new hybrid gene. Cloned into a unique plasmid and transformed into a prokaryotic host, this delta-endotoxin is active against Lepidoptera larvae, marking a significant advance in biological pest control methods.
Career Highlights
Algis Anilionis's career is marked by his work at Repligen Corporation, a company dedicated to advancing biotechnology through innovative solutions. His expertise in molecular biology has enabled him to develop critical technologies that are not only theoretical but also practically applicable in real-world scenarios.
Collaborations
Throughout his career, Algis has collaborated with notable figures in the field, including John L. Palmer and Donald A. Colbert. These partnerships have fostered a dynamic environment for innovation, leading to the creation of valuable intellectual property and advancements in bioengineering.
Conclusion
In summary, Algis Anilionis stands out as an influential inventor whose work continues to shape the biotechnology landscape. His patented inventions, particularly in recombinant proteins and biological pest control, highlight his commitment to enhancing scientific understanding and practical application in the field. As the industry evolves, his contributions will surely remain relevant and influential.